EA201690100A1 - Фармацевтический комбинированный состав капсулы, содержащий тадалафил и тамсулозин - Google Patents

Фармацевтический комбинированный состав капсулы, содержащий тадалафил и тамсулозин

Info

Publication number
EA201690100A1
EA201690100A1 EA201690100A EA201690100A EA201690100A1 EA 201690100 A1 EA201690100 A1 EA 201690100A1 EA 201690100 A EA201690100 A EA 201690100A EA 201690100 A EA201690100 A EA 201690100A EA 201690100 A1 EA201690100 A1 EA 201690100A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tamsulosin
combined composition
capsule containing
containing tadalafil
active ingredients
Prior art date
Application number
EA201690100A
Other languages
English (en)
Other versions
EA033983B1 (ru
Inventor
Калеб Хиунгмин Парк
Йонг Ил Ким
Дзае Хиун Парк
Дзонг Соо Воо
Йоунг-су Йоон
Original Assignee
Ханми Фарм. Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ханми Фарм. Ко., Лтд. filed Critical Ханми Фарм. Ко., Лтд.
Publication of EA201690100A1 publication Critical patent/EA201690100A1/ru
Publication of EA033983B1 publication Critical patent/EA033983B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Описаны комбинированный состав капсулы для предотвращения или лечения эректильной дисфункции и доброкачественной гиперплазии предстательной железы, содержащий тадалафил и тамсулозин, и способ его получения. Комбинированный состав капсулы настоящего изобретения обеспечивает полное разделение двух фармацевтически активных ингредиентов и доводит до минимума реакционноспособность между активными ингредиентами и, таким образом, обеспечивает превосходную стабильность продукта во времени, посредством этого делая максимальными его терапевтические эффекты.
EA201690100A 2013-06-28 2014-06-30 Фармацевтический комбинированный состав капсулы, содержащий тадалафил и тамсулозин EA033983B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20130076073 2013-06-28
PCT/KR2014/005813 WO2014209087A1 (en) 2013-06-28 2014-06-30 Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin

Publications (2)

Publication Number Publication Date
EA201690100A1 true EA201690100A1 (ru) 2016-04-29
EA033983B1 EA033983B1 (ru) 2019-12-17

Family

ID=52142324

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201690100A EA033983B1 (ru) 2013-06-28 2014-06-30 Фармацевтический комбинированный состав капсулы, содержащий тадалафил и тамсулозин
EA201992020A EA039091B1 (ru) 2013-06-28 2014-06-30 Фармацевтический комбинированный состав капсулы, содержащий тадалафил и тамсулозин

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201992020A EA039091B1 (ru) 2013-06-28 2014-06-30 Фармацевтический комбинированный состав капсулы, содержащий тадалафил и тамсулозин

Country Status (12)

Country Link
EP (1) EP3013327A4 (ru)
KR (1) KR102246657B1 (ru)
CN (1) CN105338970B (ru)
AU (1) AU2014299447B2 (ru)
BR (1) BR112015032728A2 (ru)
EA (2) EA033983B1 (ru)
HK (1) HK1219889A1 (ru)
MX (1) MX2015016995A (ru)
PH (1) PH12015502721B1 (ru)
RU (1) RU2672573C2 (ru)
UA (1) UA118110C2 (ru)
WO (1) WO2014209087A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016122236A1 (en) * 2015-01-28 2016-08-04 Hanmi Pharm. Co., Ltd. Composite capsules comprising raloxifene, and vitamin d or its derivatives
KR20160100570A (ko) * 2015-02-16 2016-08-24 한미약품 주식회사 탐수로신 염산염 함유 서방성 과립을 포함하는 경구용 약제학적 제제
KR102391495B1 (ko) * 2016-03-31 2022-04-28 한미약품 주식회사 안정성 및 용출율이 개선된 타다라필 및 탐수로신 함유 캡슐 복합제제
KR20170113459A (ko) * 2016-03-31 2017-10-12 한미약품 주식회사 타다라필 및 암로디핀 함유 고형 복합제제
KR101879133B1 (ko) * 2017-07-11 2018-07-17 (주)동구바이오제약 비뇨기 질환 예방 또는 치료용 제제 및 이의 제조방법
KR102169926B1 (ko) * 2018-01-12 2020-10-26 주식회사 종근당 탐스로신과 타다라필을 포함하는 약제학적 조성물
KR20210081113A (ko) 2019-12-23 2021-07-01 한미약품 주식회사 탐수로신 및 타다라필을 포함하는 경구용 복합제제 및 그 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
US20100221321A1 (en) * 2003-02-27 2010-09-02 Innercap Technologies, Inc. Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses Or Conditions
KR100706036B1 (ko) 2005-04-04 2007-04-11 대화제약 주식회사 염산 탐술로신 서방성 정제 및 그의 간단한 제조방법
DE102005016981A1 (de) * 2005-04-13 2006-10-19 Bayer Healthcare Ag Kombination zur Therapie bei benigner Prostatahyperplasie
KR100795419B1 (ko) * 2006-01-03 2008-01-17 (주)네오메딕스 암로디핀 및 아스피린을 함유하는 약학 제제
EP2106792A1 (en) * 2008-04-02 2009-10-07 Pelvipharm Use of a combination of udenafil and alfuzosin or oxybutynin for the treatment of overactive bladder
KR101861307B1 (ko) * 2011-10-13 2018-07-06 한미약품 주식회사 정제를 포함하는 경질 캡슐 복합 제형

Also Published As

Publication number Publication date
RU2016102605A3 (ru) 2018-05-15
AU2014299447A1 (en) 2015-12-17
EP3013327A4 (en) 2016-11-16
MX2015016995A (es) 2016-04-25
RU2016102605A (ru) 2017-08-02
CN105338970B (zh) 2019-07-09
EA033983B1 (ru) 2019-12-17
KR102246657B1 (ko) 2021-04-30
EA039091B1 (ru) 2021-12-02
EP3013327A1 (en) 2016-05-04
BR112015032728A2 (pt) 2017-07-25
PH12015502721A1 (en) 2016-03-14
AU2014299447B2 (en) 2019-01-17
HK1219889A1 (zh) 2017-04-21
CN105338970A (zh) 2016-02-17
EA201992020A1 (ru) 2020-01-16
WO2014209087A1 (en) 2014-12-31
UA118110C2 (uk) 2018-11-26
RU2672573C2 (ru) 2018-11-16
PH12015502721B1 (en) 2016-03-14
KR20150002550A (ko) 2015-01-07

Similar Documents

Publication Publication Date Title
EA201690100A1 (ru) Фармацевтический комбинированный состав капсулы, содержащий тадалафил и тамсулозин
EA201892395A1 (ru) Лекарственные составы ингибитора lsd1
MX2022001755A (es) Compuestos de dinucleotidos ciclicos y metodos de uso.
MX2021004639A (es) Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para uso en el tratamiento de tumores solidos.
EA201792592A1 (ru) Фармацевтические препараты, содержащие тенофовир и эмтрицитабин
EA201890654A1 (ru) Терапевтические композиции для лечения вируса иммунодефицита человека
MA40539A (fr) Procédés de formulation de compositions de conjugués anticorps-médicaments
EA202090573A1 (ru) Составы нирапариба
EA201692007A1 (ru) Соединения изоиндолинона в качестве модуляторов gpr119 для лечения диабета, ожирения, дислипидемии и связанных с ними нарушений
EA201792591A1 (ru) Фармацевтические препараты
EA201790949A1 (ru) Замещенные 2,4-диаминохинолины в качестве новых противораковых средств
MX2018012618A (es) Composiciones farmaceuticas orales de mesalazina.
MX2019014292A (es) Anillos 5-5 fusionados como inhibidores c5a.
EA201791009A1 (ru) Композиции, содержащие циклоспорин
PH12020551018A1 (en) Oral delivery of glp-1 peptide analogs
PH12019500154A1 (en) Formulation having improved ph-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof
MX2018001989A (es) Formulaciones farmaceuticas.
MX2022000803A (es) Formulaciones de capsula de cubierta blanda y metodos de preparacion y uso de las mismas.
PH12019501820A1 (en) Pharmaceutical compositions for combination therapy
EA201891680A1 (ru) Производные индана в качестве модуляторов mglur7
SG10201900879PA (en) Cdca1-derived peptide and vaccine containing same
TH165164B (th) สูตรผสมเชิงประกอบทางเภสัชกรรมของแคปซูลที่ประกอบรวมด้วยทาดาลาฟิล และแทมซูโลซิน
TH165164A (th) สูตรผสมเชิงประกอบทางเภสัชกรรมของแคปซูลที่ประกอบรวมด้วยทาดาลาฟิล และแทมซูโลซิน
GB2541348A (en) Clopidogrel for use in the treatment of benign prostatic hyperplasia
EA201201428A1 (ru) Наружное средство для лечения болезней суставов и мягких тканей

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM